View in EDS

Mitochondrial protection impairs BET bromodomain inhibitor-mediated cell death and provides rationale for combination therapeutic strategies.

Saved in:

Bibliographic Details
Title:	Mitochondrial protection impairs BET bromodomain inhibitor-mediated cell death and provides rationale for combination therapeutic strategies.
Authors:	Lasorsa E; Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, NY, USA., Smonksey M; Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, NY, USA., Kirk JS; Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, NY, USA., Rosario S; Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, NY, USA.; Department of Molecular Pharmacology and Cancer Therapeutics, State University of New York at Buffalo, Buffalo, NY, USA., Hernandez-Ilizaliturri FJ; Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA., Ellis L; Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, NY, USA.; Department of Molecular Pharmacology and Cancer Therapeutics, State University of New York at Buffalo, Buffalo, NY, USA.
Source:	Cell death & disease [Cell Death Dis] 2015 Dec 10; Vol. 6, pp. e2014. Date of Electronic Publication: 2015 Dec 10.
Publication Type:	Journal Article; Research Support, Non-U.S. Gov't
Journal Info:	Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101524092 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-4889 (Electronic) NLM ISO Abbreviation: Cell Death Dis Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	2041-4889
DOI:	10.1038/cddis.2015.352